Стоит ли избегать hydroxycortisone succinate при беременности? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Безопасен ли hydroxycortisone succinate при беременности?

EU/ECHA substance information shows harmonised classification for reproductive toxicity (Repr. 1A H360 and Repr.2 H361) for hydrocortisone 21‑hemisuccinate (CAS 2203-97-6), so this meets the criterion for confirmed reproductive hazard (h=3). The mechanism is glucocorticoid action with demonstrated ability of systemic corticosteroids to affect fetal development/placenta (m=2). For typical topical cosmetic use, systemic absorption is low (e=1), so exposure from normal topical cosmetic use is expected to be low but not zero. (Sources: ECHA brief profile / C&L inventory; guidance on topical corticosteroids in pregnancy).

Безопасен ли hydroxycortisone succinate при грудном вскармливании?

Because of the harmonised reproductive classification for the substance (see ECHA) and the known systemic effects of hydrocortisone, a conservative approach assigns h=3 for lactation context as well. Mechanistically, corticosteroids can distribute systemically and small amounts can appear in milk (m=2). For topical cosmetic application (not systemic therapy), milk exposure is generally low unless applied directly to the breast/nipple (e=1). (Sources: ECHA C&L brief profile; LactMed and NHS topical corticosteroid guidance).

Безопасен ли hydroxycortisone succinate для кожи малыша?

Harmonised classification (ECHA) indicates reproductive hazard (h=3) for the substance; that harmonised CMR classification applies as the primary hazard signal. Mechanism remains hydrocortisone (glucocorticoid) activity (m=2). Dermal exposure and systemic uptake from baby skin are higher than adult per surface‑area‑to‑weight and immature barrier — therefore exposure score is increased by +1 versus adult topical use (adult e=1 → infant e=2). There is no infant‑specific innocuousness data for cosmetic use of this specific derivative. (Sources: ECHA brief profile; EDF/dermatology and guideline reviews on topical corticosteroids/pregnancy and child skin).

Как VeriMom оценивает hydroxycortisone succinate?

VeriMom оценивает hydroxycortisone succinate в 20/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы hydroxycortisone succinate при беременности?

См. наш список безопасных альтернатив hydroxycortisone succinate с аналогичной функцией и классификацией без известных рисков.